articleEntity Profile

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

CNBC · article

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

View source →https://www.cnbc.com/2026/10/20/novo-cagrisema-women-weight-loss-analysis.html

Hash 0x664986b0ecde1ccef8d27a56bd400ca4e1359cda970e3236ee76a7ba4c3c61be

Score—

AI—

Tips0 ETH

(0)

—

Discussion

Connect your wallet to join the discussion.

No comments yet. Be the first to share your take.

TUE, 20 OCT 2026 · EDITION 224 · BASE L2